DocuSign CFO Disposes 9,509 Shares; Sales Executed via Rule 10b5-1
Rhea-AI Filing Summary
DocuSign Chief Financial Officer Blake Grayson sold a total of 9,509 shares of DocuSign, Inc. (ticker DOCU) on 09/17/2025 under a pre-established Rule 10b5-1 trading plan. The sales consisted of 5,658 shares at prices ranging from $82.22 to $83.18 and 3,851 shares at prices ranging from $83.20 to $83.65. Following the transactions the reporting person beneficially owned 116,011 shares after the first sale and 112,160 shares after the second sale, reported as direct ownership. The Form 4 was signed by an attorney-in-fact.
Positive
- Sales were executed under a Rule 10b5-1 plan, indicating pre-authorized trading rather than ad-hoc insider timing.
- Filing discloses price ranges for the sales and offers to provide per-price quantities on request, supporting transparency.
- Reporting person retains significant direct ownership (112,160 shares reported after the second sale).
Negative
- Form 4 does not state ownership as a percentage of outstanding shares, limiting assessment of economic stake relative to company size.
Insights
TL;DR: Insider sales by the CFO totaled 9,509 shares under a Rule 10b5-1 plan, with reported direct ownership remaining material.
The filing documents routine, pre-planned disposals rather than open-market timing. Sales were executed through a Rule 10b5-1 plan, which indicates pre-authorized trades and reduces likelihood these reflect new, contemporaneous company-specific material information. The remaining direct holdings (reported as 112,160 shares after the second transaction) show the CFO retains a meaningful stake, though the Form 4 does not state the percentage ownership relative to outstanding shares. Transactions were at prices between $82.22 and $83.65, and the filer has offered to provide a breakdown of quantities per price on request.
TL;DR: Sales are documented and executed under a documented plan; disclosure appears compliant and transparent.
The Form 4 clearly discloses the relationship (Chief Financial Officer), the Rule 10b5-1 plan usage, and price ranges for the executed sales with an offer to provide granularity on request. The signature by an attorney-in-fact is included, which is acceptable where authorized. There is no indication in the filing of other derivative transactions or amendments. From a governance perspective, the filing meets standard disclosure practices for insider disposals.